Baader Bank Aktiengesellschaft’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
VCM
VPM
Baader Bank Aktiengesellschaft's EW Position: Q1 2026 in Review
Baader Bank Aktiengesellschaft reduced its Edwards Lifesciences (EW) stake by 7.2% in Q1 2026, selling an estimated $484K and leaving 75,561 shares worth $6.04M. The position accounts for 0.47% of the portfolio, ranked #48.
Baader Bank Aktiengesellschaft first reported a position in EW in Q4 2021 and has held it in 18 quarters since. The position peaked at $13.8M in Q1 2024. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Baader Bank Aktiengesellschaft held 75,561 shares of Edwards Lifesciences worth $6.04M as of Q1 2026.
- Baader Bank Aktiengesellschaft sold 5,867 Edwards Lifesciences shares in Q1 2026, an estimated $484K.
- Edwards Lifesciences made up 0.47% of Baader Bank Aktiengesellschaft's portfolio in Q1 2026, its #48 holding.
- Baader Bank Aktiengesellschaft first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 18 quarters since.
- Baader Bank Aktiengesellschaft's Edwards Lifesciences position peaked at $13.8M in Q1 2024.
- 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Baader Bank Aktiengesellschaft's 13F filing for Q1 2026, filed 8 May 2026.